Sfoglia per Rivista
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy
2015-01-01 Santoni, M.; Buti, S.; Conti, A.; Porta, C.; Procopio, G.; Sternberg, C. N.; Bracarda, S.; Basso, U.; De Giorgi, U.; Rizzo, M.; Derosa, L.; Ortega, C.; Massari, F.; Milella, M.; Bersanelli, M.; Cerbone, L.; Muzzonigro, G.; Burattini, L.; Montironi, R.; Santini, D.; Cascinu, S.
Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study)
2024-01-01 Fiala, Ondřej; Buti, Sebastiano; Bamias, Aristotelis; Massari, Francesco; Pichler, Renate; Maruzzo, Marco; Grande, Enrique; De Giorgi, Ugo; Molina-Cerrillo, Javier; Seront, Emmanuel; Calabrò, Fabio; Myint, Zin W; Facchini, Gaetano; Kopp, Ray Manneh; Berardi, Rossana; Kucharz, Jakub; Vitale, Maria Giuseppa; Pinto, Alvaro; Formisano, Luigi; Büttner, Thomas; Messina, Carlo; Monteiro, Fernando Sabino M; Battelli, Nicola; Kanesvaran, Ravindran; Büchler, Tomáš; Kopecký, Jindřich; Santini, Daniele; Giudice, Giulia Claire; Porta, Camillo; Santoni, Matteo
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial
2023-01-01 Motzer, Robert J; Russo, Paul; Grünwald, Viktor; Tomita, Yoshihiko; Zurawski, Bogdan; Parikh, Omi; Buti, Sebastiano; Barthélémy, Philippe; Goh, Jeffrey C; Ye, Dingwei; Lingua, Alejo; Lattouf, Jean-Baptiste; Albigès, Laurence; George, Saby; Shuch, Brian; Sosman, Jeffrey; Staehler, Michael; Vázquez Estévez, Sergio; Simsek, Burcin; Spiridigliozzi, Julia; Chudnovsky, Aleksander; Bex, Axel
The Urinary Microbiome and Anticancer Immunotherapy: The Potentially Hidden Role of Unculturable Microbes
2019-01-01 Bersanelli, M.; Santoni, M.; Ticinesi, A.; Buti, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy | 1-gen-2015 | Santoni, M.; Buti, S.; Conti, A.; Porta, C.; Procopio, G.; Sternberg, C. N.; Bracarda, S.; Basso, U.; De Giorgi, U.; Rizzo, M.; Derosa, L.; Ortega, C.; Massari, F.; Milella, M.; Bersanelli, M.; Cerbone, L.; Muzzonigro, G.; Burattini, L.; Montironi, R.; Santini, D.; Cascinu, S. | |
| Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study) | 1-gen-2024 | Fiala, Ondřej; Buti, Sebastiano; Bamias, Aristotelis; Massari, Francesco; Pichler, Renate; Maruzzo, Marco; Grande, Enrique; De Giorgi, Ugo; Molina-Cerrillo, Javier; Seront, Emmanuel; Calabrò, Fabio; Myint, Zin W; Facchini, Gaetano; Kopp, Ray Manneh; Berardi, Rossana; Kucharz, Jakub; Vitale, Maria Giuseppa; Pinto, Alvaro; Formisano, Luigi; Büttner, Thomas; Messina, Carlo; Monteiro, Fernando Sabino M; Battelli, Nicola; Kanesvaran, Ravindran; Büchler, Tomáš; Kopecký, Jindřich; Santini, Daniele; Giudice, Giulia Claire; Porta, Camillo; Santoni, Matteo | |
| Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial | 1-gen-2023 | Motzer, Robert J; Russo, Paul; Grünwald, Viktor; Tomita, Yoshihiko; Zurawski, Bogdan; Parikh, Omi; Buti, Sebastiano; Barthélémy, Philippe; Goh, Jeffrey C; Ye, Dingwei; Lingua, Alejo; Lattouf, Jean-Baptiste; Albigès, Laurence; George, Saby; Shuch, Brian; Sosman, Jeffrey; Staehler, Michael; Vázquez Estévez, Sergio; Simsek, Burcin; Spiridigliozzi, Julia; Chudnovsky, Aleksander; Bex, Axel | |
| The Urinary Microbiome and Anticancer Immunotherapy: The Potentially Hidden Role of Unculturable Microbes | 1-gen-2019 | Bersanelli, M.; Santoni, M.; Ticinesi, A.; Buti, S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile